首頁 > 市場調查報告書 > 製藥

生物製劑

市場調查報告書

商品編碼

1563122

藍色生物技術的全球市場：依產品、應用、最終用戶和地區的預測（~2032年）

Global Blue Biotechnology Market Research Report Information by Product, by Application, and by End User and by Region - Forecast till 2032

出版日期: 2024年08月10日 | 出版商:

Market Research Future | 英文 131 Pages | 訂單完成後即時交付

價格

簡介目錄圖表

藍色生技市場規模預計將從2024年的56.5億美元成長到2032年的105.4億美元，預測期內年複合成長率為 7.15%。與源自海洋生物的藥品和營養保健品相關的策略性舉措以及基於藍色生物技術的營養保健品和藥品的意識不斷增強等因素推動市場的成長。

提高對基於藍色生物技術的營養保健品和藥物的認識是同一市場成長的關鍵因素。隨著消費者越來越意識到海鮮的健康益處，對海洋生物產品的需求也不斷增加。含有 omega-3 脂肪酸、抗氧化劑和礦物質等海洋成分的膳食補充劑因其健康益處而變得越來越受歡迎。

區域洞察

由於研發活動投資增加、醫療保健基礎設施改善以及成熟製藥製造商在該地區的存在，2023年北美地區的市場佔有率最大，約為 36.04%。

由於大量新興公司的存在，預計歐洲市場在預測期內將大幅擴張。

由於農業、製藥和化妝品等行業對海洋衍生產品的需求不斷成長，預計亞太市場在預測期內將發展最快。此外，基因組學、蛋白質組學和代謝組學等生物技術工具和技術的改進使得研究和利用海洋資源變得更加容易，推動了市場成長。這些技術使研究人員能夠更有效地檢測、分離和提取海洋資源中的重要化學物質。

本報告調查了全球藍色生物技術市場，提供了市場的定義和概述，市場成長的各種影響因素分析，市場規模推移和預測，各種區分、地區的細分，競爭環境，主要企業概況等彙整資料。

Global Blue Biotechnology Market Research Report Information by Product (Enzymes, Pharma Products, Bulk Chemicals, and Others), by Application (Bioengineering, Genomics, Vaccine Development, Drug Discovery, Fisheries, Aquaculture, Biofuels, Water Treatment Services, and Others), and by End User (Hospitals, Pharmaceutical Companies, Biotechnology Companies, and Others) and by Region (North America, Europe, Asia-Pacific, and Rest of the World) - Forecast till 2032

Market Overview

The Blue Biotechnology Market is expected to increase from USD 5.65 billion in 2024 to USD 10.54 billion by 2032, with a compound annual growth rate (CAGR) of 7.15% over the forecast period (2024-2032). The global market is being driven by increased awareness of blue biotechnology-based nutraceuticals and pharmaceuticals, as well as strategic initiatives involving medicines and nutraceuticals derived from marine creatures.

The growing awareness of blue biotechnology-based nutraceuticals and medicines is a key factor driving the blue biotechnology industry forward. As consumers become more aware of the health benefits of marine-derived substances, there is an increasing demand for items derived from marine species. Nutraceuticals containing marine components, such as omega-3 fatty acids, antioxidants, and minerals, are becoming increasingly popular due to their supposed health benefits.

Furthermore, a surge in strategic activities aiming at pharmaceutical and nutraceutical goods generated from marine organisms is propelling the Blue Biotechnology Market. As the pharmaceutical and nutraceutical companies seek new ways to address increasing healthcare and dietary demands, their attention has switched to the ocean's immense and largely unexplored resources.

Market Segment insights

The Blue Biotechnology Market is divided into several product categories, including enzymes, pharmaceuticals, bulk chemicals, biopolymers, and others.

The Blue Biotechnology Market is divided into several types, including bioengineering, genomics, vaccine development, drug research, fisheries, aquaculture, biofuels, water treatment services, and others.

The blue biotechnology market is divided into four end user segments: hospitals, pharmaceutical firms, biotechnology businesses, and others.

Regional insights

The market is segmented into four regions: North America, Europe, Asia-Pacific, and the rest of the world. North America had the biggest market share of approximately 36.04% in 2023, owing to increased investment in R&D activities, improved healthcare infrastructure, and the presence of established medication manufacturers in the region. Furthermore, the presence of well-known industry players who are actively involved in meeting consumer demand in the region is boosting the market's growth.

The European blue biotechnology market is expected to increase significantly during the forecast year, 2024-2032, due to the existence of numerous blue biotechnology start-ups. For example, the Calouste Gulbenkian and Oceano Azul Foundations, both based in Portugal, have received more than 120 blue biotechnology-related proposals from over 30 countries through September 2020.

The Asia-Pacific blue biotechnology market is expected to develop the quickest over the forecast period, driven by rising demand for marine-derived goods in industries such as agriculture, medicines, and cosmetics. Furthermore, improvements in biotechnological tools and techniques such as genomics, proteomics, and metabolomics have made it easier to research and use marine resources, resulting in increased market growth. These methods enable researchers to more efficiently detect, isolate, and extract important chemicals from marine species.

Major Players

Marinomed Biotech AG (Austria), Marshall Marine Products (India), Marinova (Australia), Aker BioMarine (Norway), Pharma Mar (Spain), Cyanotech Corporation (US), ADM (US), Geomarine (India), CP Kelco U.S., Inc. (US), and TerSera Therapeutics LLC (US) are among the key players in the Blue Biotechnology Market.

1 EXECUTIVE SUMMARY

1.1 OVERVIEW

2 MARKET INTRODUCTION

2.1 DEFINITION
2.2 SCOPE OF THE STUDY
2.3 RESEARCH OBJECTIVE
2.4 MARKET STRUCTURE
2.5 ASSUMPTIONS & LIMITATIONS

3 RESEARCH METHODOLOGY

3.1 DATA MINING
3.2 SECONDARY RESEARCH
3.3 PRIMARY RESEARCH
3.4 BREAKDOWN OF PRIMARY RESPONDENTS
3.5 FORECASTING TECHNIQUES
3.6 RESEARCH METHODOLOGY FOR MARKET SIZE ESTIMATION
- 3.6.1 BOTTOM-UP APPROACH
- 3.6.2 TOP-DOWN APPROACH
3.7 DATA TRIANGULATION
3.8 VALIDATION

4 MARKET DYNAMICS

4.1 OVERVIEW
4.2 DRIVERS
- 4.2.1 INCREASING AWARENESS OF BLUE BIOTECHNOLOGY-BASED NUTRACEUTICALS AND PHARMACEUTICALS
- 4.2.2 RISING STRATEGIC INITIATIVES ASSOCIATED WITH PHARMACEUTICALS AND NUTRACEUTICALS SOURCED FROM MARINE ORGANISMS
4.3 RESTRAINTS
- 4.3.1 STRINGENT REGULATORY POLICIES
4.4 OPPORTUNITIES
- 4.4.1 INCREASING INVESTMENT IN THE DEVELOPMENT OF BIOTECHNOLOGY-BASED MEDICINE

5 MARKET FACTOR ANALYSIS

5.1 PORTER'S FIVE FORCES MODEL
- 5.1.1 THREAT OF NEW ENTRANTS
- 5.1.2 BARGAINING POWER OF SUPPLIERS
- 5.1.3 THREAT OF SUBSTITUTES
- 5.1.4 BARGAINING POWER OF BUYERS
- 5.1.5 INTENSITY OF RIVALRY
5.2 IMPACT OF COVID-19 ON THE INDIA CELL CULTURE MEDIA MARKET
- 5.2.1 IMPACT ON SUPPLY CHAIN

6 GLOBAL BLUE BIOTECHNOLOGY MARKET, BY PRODUCT

6.1 OVERVIEW
6.2 ENZYMES
6.3 PHARMA PRODUCTS
6.4 BULK CHEMICALS
6.5 BIOPOLYMERS
6.6 OTHERS

7 GLOBAL BLUE BIOTECHNOLOGY MARKET, BY APPLICATION

7.1 OVERVIEW
7.2 BIOENGINEERING
7.3 GENOMICS
7.4 VACCINE DEVELOPMENT
7.5 DRUG DISCOVERY
7.6 FISHERIES
7.7 AQUACULTURE
7.8 BIOFUELS
7.9 WATER TREATMENT SERVICES
7.10 OTHERS

8 GLOBAL BLUE BIOTECHNOLOGY MARKET, BY END USER

8.1 OVERVIEW
8.2 HOSPITALS
8.3 PHARMACEUTICAL COMPANIES
8.4 BIOTECHNOLOGY COMPANIES
8.5 OTHERS

9 GLOBAL BLUE BIOTECHNOLOGY MARKET, BY REGION

9.1 OVERVIEW
9.2 NORTH AMERICA
- 9.2.1 US
- 9.2.2 CANADA
9.3 EUROPE
- 9.3.1 GERMANY
- 9.3.2 FRANCE
- 9.3.3 UK
- 9.3.4 ITALY
- 9.3.5 SPAIN
- 9.3.6 NORWAY
- 9.3.7 NETHERLANDS
- 9.3.8 SWITZERLAND
- 9.3.9 FINLAND
- 9.3.10 BELGIUM
- 9.3.11 REST OF EUROPE
9.4 ASIA-PACIFIC
- 9.4.1 CHINA
- 9.4.2 INDIA
- 9.4.3 JAPAN
- 9.4.4 AUSTRALIA
- 9.4.5 SOUTH KOREA
- 9.4.6 REST OF ASIA-PACIFIC
9.5 REST OF THE WORLD
- 9.5.1 LATIN AMERICA
- 9.5.2 MIDDLE EAST
- 9.5.3 AFRICA

10 COMPETITIVE LANDSCAPE

10.1 OVERVIEW
10.2 COMPETITIVE BENCHMARKING
10.3 MAJOR GROWTH STRATEGY IN THE BLUE BIOTECHNOLOGY MARKET
10.4 THE LEADING PLAYER IN TERMS OF THE NUMBER OF DEVELOPMENTS IN THE BLUE BIOTECHNOLOGY MARKET
10.5 KEY DEVELOPMENT ANALYSIS
10.6 KEY DEVELOPMENTS & GROWTH STRATEGIES
- 10.6.1 PRODUCT LAUNCH / PRODUCT APPROVAL
- 10.6.2 AGREEMENT
- 10.6.3 PARTNERSHIP
- 10.6.4 ACQUISITION
10.7 MAJOR PLAYERS FINANCIAL
- 10.7.1 SALES (USD MILLION),
- 10.7.2 RESEARCH & DEVELOPMENT EXPENDITURE (USD MILLION),

11 COMPANY PROFILES

11.1 MARINOMED BIOTECH AG
- 11.1.1 COMPANY OVERVIEW
- 11.1.2 FINANCIAL OVERVIEW
- 11.1.3 PRODUCTS OFFERED
- 11.1.4 KEY DEVELOPMENTS
- 11.1.5 KEY STRATEGIES
11.2 MARSHALL MARINE PRODUCTS/
- 11.2.1 COMPANY OVERVIEW
- 11.2.2 FINANCIAL OVERVIEW
- 11.2.3 PRODUCTS OFFERED
- 11.2.4 KEY DEVELOPMENTS
- 11.2.5 KEY STRATEGIES
11.3 MARINOVA
- 11.3.1 COMPANY OVERVIEW
- 11.3.2 FINANCIAL OVERVIEW
- 11.3.3 PRODUCTS OFFERED
- 11.3.4 KEY DEVELOPMENTS
- 11.3.5 SWOT ANALYSIS
- 11.3.6 KEY STRATEGIES
11.4 AKER BIOMARINE
- 11.4.1 COMPANY OVERVIEW
- 11.4.2 FINANCIAL OVERVIEW
- 11.4.3 PRODUCTS OFFERED
- 11.4.4 KEY DEVELOPMENTS
- 11.4.5 SWOT ANALYSIS
- 11.4.6 KEY STRATEGIES
11.5 PHARMAMAR
- 11.5.1 COMPANY OVERVIEW
- 11.5.2 FINANCIAL OVERVIEW
- 11.5.3 PRODUCTS OFFERED
- 11.5.4 KEY DEVELOPMENTS
- 11.5.5 SWOT ANALYSIS
- 11.5.6 KEY STRATEGIES
11.6 CYANOTECH CORPORATION
- 11.6.1 COMPANY OVERVIEWS
- 11.6.2 FINANCIAL OVERVIEW
- 11.6.3 PRODUCTS OFFERED
- 11.6.4 KEY DEVELOPMENTS
- 11.6.5 KEY STRATEGIES
11.7 ADM
- 11.7.1 COMPANY OVERVIEW
- 11.7.2 FINANCIAL ANALYSIS
- 11.7.3 PRODUCTS OFFERED
- 11.7.4 KEY DEVELOPMENTS
- 11.7.5 SWOT ANALYSIS
- 11.7.6 KEY STRATEGIES
11.8 GEOMARINE BIOTECHNOLOGIES
- 11.8.1 COMPANY OVERVIEW
- 11.8.2 FINANCIAL OVERVIEW
- 11.8.3 PRODUCTS OFFERED
- 11.8.4 KEY DEVELOPMENTS
- 11.8.5 KEY STRATEGIES
11.9 CP KELCO U.S., INC.
- 11.9.1 COMPANY OVERVIEW
- 11.9.2 FINANCIAL OVERVIEW
- 11.9.3 PRODUCT OFFERED
- 11.9.4 KEY DEVELOPMENTS
- 11.9.5 KEY STRATEGIES
11.10 TERSERA THERAPEUTICS LLC
- 11.10.1 COMPANY OVERVIEW
- 11.10.2 FINANCIAL OVERVIEW
- 11.10.3 PRODUCTS OFFERED
- 11.10.4 KEY DEVELOPMENTS
- 11.10.5 SWOT ANALYSIS
- 11.10.6 KEY STRATEGIES

12 APPENDIX

12.1 REFERENCES
12.2 RELATED REPORTS

簡介目錄圖表

LIST OF TABLES

TABLE 1 LIST OF ASSUMPTIONS & LIMITATIONS
TABLE 2 PRIMARY INTERVIEWS AND INFORMATION GATHERING PROCESS
TABLE 3 GLOBAL BLUE BIOTECHNOLOGY MARKET, BY PRODUCT, 2019-2032 (USD MILLION)
TABLE 4 GLOBAL BLUE BIOTECHNOLOGY MARKET, FOR ENZYMES, BY REGION, 2019-2032 (USD MILLION)
TABLE 5 GLOBAL BLUE BIOTECHNOLOGY MARKET, FOR PHARMA PRODUCTS, BY REGION, 2019-2032 (USD MILLION)
TABLE 6 GLOBAL BLUE BIOTECHNOLOGY MARKET, FOR BULK CHEMICALS, BY REGION, 2019-2032 (USD MILLION)
TABLE 7 GLOBAL BLUE BIOTECHNOLOGY MARKET, FOR BIOPOLYMERS, BY REGION, 2019-2032 (USD MILLION)
TABLE 8 GLOBAL BLUE BIOTECHNOLOGY MARKET, FOR OTHERS, BY REGION, 2019-2032 (USD MILLION)
TABLE 9 GLOBAL BLUE BIOTECHNOLOGY MARKET, BY APPLICATION, 2019-2032 (USD MILLION)
TABLE 10 GLOBAL BLUE BIOTECHNOLOGY MARKET, FOR BIOENGINEERING, BY REGION, 2019-2032 (USD MILLION)
TABLE 11 GLOBAL BLUE BIOTECHNOLOGY MARKET, FOR GENOMICS, BY REGION, 2019-2032 (USD MILLION)
TABLE 12 GLOBAL BLUE BIOTECHNOLOGY MARKET, FOR VACCINE DEVELOPMENT, BY REGION, 2019-2032 (USD MILLION)
TABLE 13 GLOBAL BLUE BIOTECHNOLOGY MARKET, FOR DRUG DISCOVERY, BY REGION, 2019-2032 (USD MILLION)
TABLE 14 GLOBAL BLUE BIOTECHNOLOGY MARKET, FOR FISHERIES, BY REGION, 2019-2032 (USD MILLION)
TABLE 15 GLOBAL BLUE BIOTECHNOLOGY MARKET, FOR AQUACULTURE, BY REGION, 2019-2032 (USD MILLION)
TABLE 16 GLOBAL BLUE BIOTECHNOLOGY MARKET, FOR BIOFUELS, BY REGION, 2019-2032 (USD MILLION)
TABLE 17 GLOBAL BLUE BIOTECHNOLOGY MARKET, FOR WATER TREATMENT SERVICES, BY REGION, 2019-2032 (USD MILLION)
TABLE 18 GLOBAL BLUE BIOTECHNOLOGY MARKET, FOR OTHERS, BY REGION, 2019-2032 (USD MILLION)
TABLE 19 GLOBAL BLUE BIOTECHNOLOGY MARKET, BY END USER, 2019-2032 (USD MILLION)
TABLE 20 GLOBAL BLUE BIOTECHNOLOGY MARKET, FOR HOSPITALS, BY REGION, 2019-2032 (USD MILLION)
TABLE 21 GLOBAL BLUE BIOTECHNOLOGY MARKET, FOR PHARMACEUTICAL COMPANIES, BY REGION, 2019-2032 (USD MILLION)
TABLE 22 GLOBAL BLUE BIOTECHNOLOGY MARKET, FOR BIOTECHNOLOGY COMPANIES, BY REGION, 2019-2032 (USD MILLION)
TABLE 23 GLOBAL BLUE BIOTECHNOLOGY MARKET, FOR OTHERS, BY REGION, 2019-2032 (USD MILLION)
TABLE 24 NORTH AMERICA: BLUE BIOTECHNOLOGY MARKET, BY COUNTRY, 2019-2032 (USD MILLION)
TABLE 25 NORTH AMERICA: BLUE BIOTECHNOLOGY MARKET, BY PRODUCT, 2019-2032 (USD MILLION)
TABLE 26 NORTH AMERICA: BLUE BIOTECHNOLOGY MARKET, BY APPLICATION, 2019-2032 (USD MILLION)
TABLE 27 NORTH AMERICA: BLUE BIOTECHNOLOGY MARKET, BY END USER, 2019-2032 (USD MILLION)
TABLE 28 US: BLUE BIOTECHNOLOGY MARKET, BY PRODUCT, 2019-2032 (USD MILLION)
TABLE 29 US: BLUE BIOTECHNOLOGY MARKET, BY APPLICATION, 2019-2032 (USD MILLION)
TABLE 30 US: BLUE BIOTECHNOLOGY MARKET, BY END USER, 2019-2032 (USD MILLION)
TABLE 31 CANADA: BLUE BIOTECHNOLOGY MARKET, BY PRODUCT, 2019-2032 (USD MILLION)
TABLE 32 CANADA: BLUE BIOTECHNOLOGY MARKET, BY APPLICATION, 2019-2032 (USD MILLION)
TABLE 33 CANADA: BLUE BIOTECHNOLOGY MARKET, BY END USER, 2019-2032 (USD MILLION)
TABLE 34 EUROPE: BLUE BIOTECHNOLOGY MARKET, BY COUNTRY, 2019-2032 (USD MILLION)
TABLE 35 EUROPE: BLUE BIOTECHNOLOGY MARKET, BY PRODUCT, 2019-2032 (USD MILLION)
TABLE 36 EUROPE: BLUE BIOTECHNOLOGY MARKET, BY APPLICATION, 2019-2032 (USD MILLION)
TABLE 37 EUROPE: BLUE BIOTECHNOLOGY MARKET, BY END USER, 2019-2032 (USD MILLION)
TABLE 38 GERMANY: BLUE BIOTECHNOLOGY MARKET, BY PRODUCT, 2019-2032 (USD MILLION)
TABLE 39 GERMANY: BLUE BIOTECHNOLOGY MARKET, BY APPLICATION, 2019-2032 (USD MILLION)
TABLE 40 GERMANY: BLUE BIOTECHNOLOGY MARKET, BY END USER, 2019-2032 (USD MILLION)
TABLE 41 FRANCE: BLUE BIOTECHNOLOGY MARKET, BY PRODUCT, 2019-2032 (USD MILLION)
TABLE 42 FRANCE: BLUE BIOTECHNOLOGY MARKET, BY APPLICATION, 2019-2032 (USD MILLION)
TABLE 43 FRANCE: BLUE BIOTECHNOLOGY MARKET, BY END USER, 2019-2032 (USD MILLION)
TABLE 44 UK: BLUE BIOTECHNOLOGY MARKET, BY PRODUCT, 2019-2032 (USD MILLION)
TABLE 45 UK: BLUE BIOTECHNOLOGY MARKET, BY APPLICATION, 2019-2032 (USD MILLION)
TABLE 46 UK: BLUE BIOTECHNOLOGY MARKET, BY END USER, 2019-2032 (USD MILLION)
TABLE 47 ITALY: BLUE BIOTECHNOLOGY MARKET, BY PRODUCT, 2019-2032 (USD MILLION)
TABLE 48 ITALY: BLUE BIOTECHNOLOGY MARKET, BY APPLICATION, 2019-2032 (USD MILLION)
TABLE 49 ITALY: BLUE BIOTECHNOLOGY MARKET, BY END USER, 2019-2032 (USD MILLION)
TABLE 50 SPAIN: BLUE BIOTECHNOLOGY MARKET, BY PRODUCT, 2019-2032 (USD MILLION)
TABLE 51 SPAIN: BLUE BIOTECHNOLOGY MARKET, BY APPLICATION, 2019-2032 (USD MILLION)
TABLE 52 SPAIN: BLUE BIOTECHNOLOGY MARKET, BY END USER, 2019-2032 (USD MILLION)
TABLE 53 NORWAY: BLUE BIOTECHNOLOGY MARKET, BY PRODUCT, 2019-2032 (USD MILLION)
TABLE 54 NORWAY: BLUE BIOTECHNOLOGY MARKET, BY APPLICATION, 2019-2032 (USD MILLION)
TABLE 55 NORWAY: BLUE BIOTECHNOLOGY MARKET, BY END USER, 2019-2032 (USD MILLION)
TABLE 56 NETHERLANDS: BLUE BIOTECHNOLOGY MARKET, BY PRODUCT, 2019-2032 (USD MILLION)
TABLE 57 NETHERLANDS: BLUE BIOTECHNOLOGY MARKET, BY APPLICATION, 2019-2032 (USD MILLION)
TABLE 58 NETHERLANDS: BLUE BIOTECHNOLOGY MARKET, BY END USER, 2019-2032 (USD MILLION)
TABLE 59 SWITZERLAND: BLUE BIOTECHNOLOGY MARKET, BY PRODUCT, 2019-2032 (USD MILLION)
TABLE 60 SWITZERLAND: BLUE BIOTECHNOLOGY MARKET, BY APPLICATION, 2019-2032 (USD MILLION)
TABLE 61 SWITZERLAND: BLUE BIOTECHNOLOGY MARKET, BY END USER, 2019-2032 (USD MILLION)
TABLE 62 FINLAND: BLUE BIOTECHNOLOGY MARKET, BY PRODUCT, 2019-2032 (USD MILLION)
TABLE 63 FINLAND: BLUE BIOTECHNOLOGY MARKET, BY APPLICATION, 2019-2032 (USD MILLION)
TABLE 64 FINLAND: BLUE BIOTECHNOLOGY MARKET, BY END USER, 2019-2032 (USD MILLION)
TABLE 65 BELGIUM: BLUE BIOTECHNOLOGY MARKET, BY PRODUCT, 2019-2032 (USD MILLION)
TABLE 66 BELGIUM: BLUE BIOTECHNOLOGY MARKET, BY APPLICATION, 2019-2032 (USD MILLION)
TABLE 67 BELGIUM: BLUE BIOTECHNOLOGY MARKET, BY END USER, 2019-2032 (USD MILLION)
TABLE 68 REST OF EUROPE: BLUE BIOTECHNOLOGY MARKET, BY PRODUCT, 2019-2032 (USD MILLION)
TABLE 69 REST OF EUROPE: BLUE BIOTECHNOLOGY MARKET, BY APPLICATION, 2019-2032 (USD MILLION)
TABLE 70 REST OF EUROPE: BLUE BIOTECHNOLOGY MARKET, BY END USER, 2019-2032 (USD MILLION)
TABLE 71 ASIA-PACIFIC: BLUE BIOTECHNOLOGY MARKET, BY COUNTRY, 2019-2032 (USD MILLION)
TABLE 72 ASIA-PACIFIC: BLUE BIOTECHNOLOGY MARKET, BY PRODUCT, 2019-2032 (USD MILLION)
TABLE 73 ASIA-PACIFIC: BLUE BIOTECHNOLOGY MARKET, BY APPLICATION, 2019-2032 (USD MILLION)
TABLE 74 ASIA-PACIFIC: BLUE BIOTECHNOLOGY MARKET, BY END USER, 2019-2032 (USD MILLION)
TABLE 75 CHINA: BLUE BIOTECHNOLOGY MARKET, BY PRODUCT, 2019-2032 (USD MILLION)
TABLE 76 CHINA: BLUE BIOTECHNOLOGY MARKET, BY APPLICATION, 2019-2032 (USD MILLION)
TABLE 77 CHINA: BLUE BIOTECHNOLOGY MARKET, BY END USER, 2019-2032 (USD MILLION)
TABLE 78 INDIA: BLUE BIOTECHNOLOGY MARKET, BY PRODUCT, 2019-2032 (USD MILLION)
TABLE 79 INDIA: BLUE BIOTECHNOLOGY MARKET, BY APPLICATION, 2019-2032 (USD MILLION)
TABLE 80 INDIA: BLUE BIOTECHNOLOGY MARKET, BY END USER, 2019-2032 (USD MILLION)
TABLE 81 JAPAN: BLUE BIOTECHNOLOGY MARKET, BY PRODUCT, 2019-2032 (USD MILLION)
TABLE 82 JAPAN: BLUE BIOTECHNOLOGY MARKET, BY APPLICATION, 2019-2032 (USD MILLION)
TABLE 83 JAPAN: BLUE BIOTECHNOLOGY MARKET, BY END USER, 2019-2032 (USD MILLION)
TABLE 84 AUSTRALIA: BLUE BIOTECHNOLOGY MARKET, BY PRODUCT, 2019-2032 (USD MILLION)
TABLE 85 AUSTRALIA: BLUE BIOTECHNOLOGY MARKET, BY APPLICATION, 2019-2032 (USD MILLION)
TABLE 86 AUSTRALIA: BLUE BIOTECHNOLOGY MARKET, BY END USER, 2019-2032 (USD MILLION)
TABLE 87 SOUTH KOREA: BLUE BIOTECHNOLOGY MARKET, BY PRODUCT, 2019-2032 (USD MILLION)
TABLE 88 SOUTH KOREA: BLUE BIOTECHNOLOGY MARKET, BY APPLICATION, 2019-2032 (USD MILLION)
TABLE 89 SOUTH KOREA: BLUE BIOTECHNOLOGY MARKET, BY END USER, 2019-2032 (USD MILLION)
TABLE 90 REST OF ASIA-PACIFIC: BLUE BIOTECHNOLOGY MARKET, BY PRODUCT, 2019-2032 (USD MILLION)
TABLE 91 REST OF ASIA-PACIFIC: BLUE BIOTECHNOLOGY MARKET, BY APPLICATION, 2019-2032 (USD MILLION)
TABLE 92 REST OF ASIA-PACIFIC: BLUE BIOTECHNOLOGY MARKET, BY END USER, 2019-2032 (USD MILLION)
TABLE 93 REST OF THE WORLD: BLUE BIOTECHNOLOGY MARKET, BY COUNTRY, 2019-2032 (USD MILLION)
TABLE 94 REST OF THE WORLD: BLUE BIOTECHNOLOGY MARKET, BY PRODUCT, 2019-2032 (USD MILLION)
TABLE 95 REST OF THE WORLD: BLUE BIOTECHNOLOGY MARKET, BY APPLICATION, 2019-2032 (USD MILLION)
TABLE 96 REST OF THE WORLD: BLUE BIOTECHNOLOGY MARKET, BY END USER, 2019-2032 (USD MILLION)
TABLE 97 LATIN AMERICA: BLUE BIOTECHNOLOGY MARKET, BY PRODUCT, 2019-2032 (USD MILLION)
TABLE 98 LATIN AMERICA: BLUE BIOTECHNOLOGY MARKET, BY APPLICATION, 2019-2032 (USD MILLION)
TABLE 99 LATIN AMERICA: BLUE BIOTECHNOLOGY MARKET, BY END USER, 2019-2032 (USD MILLION)
TABLE 100 MIDDLE EAST: BLUE BIOTECHNOLOGY MARKET, BY PRODUCT, 2019-2032 (USD MILLION)
TABLE 101 MIDDLE EAST: BLUE BIOTECHNOLOGY MARKET, BY APPLICATION, 2019-2032 (USD MILLION)
TABLE 102 MIDDLE EAST: BLUE BIOTECHNOLOGY MARKET, BY END USER, 2019-2032 (USD MILLION)
TABLE 103 AFRICA: BLUE BIOTECHNOLOGY MARKET, BY PRODUCT, 2019-2032 (USD MILLION)
TABLE 104 AFRICA: BLUE BIOTECHNOLOGY MARKET, BY APPLICATION, 2019-2032 (USD MILLION)
TABLE 105 AFRICA: BLUE BIOTECHNOLOGY MARKET, BY END USER, 2019-2032 (USD MILLION)
TABLE 106 MAJOR PLAYERS IN THE BLUE BIOTECHNOLOGY MARKET
TABLE 107 MOST ACTIVE PLAYER IN THE BLUE BIOTECHNOLOGY MARKET
TABLE 108 PRODUCT LAUNCH / PRODUCT APPROVAL
TABLE 109 AGREEMENT
TABLE 110 PARTNERSHIP
TABLE 111 ACQUISITION
TABLE 112 MARINOMED BIOTECH AG: PRODUCTS OFFERED
TABLE 113 MARINOMED BIOTECH AG: KEY DEVELOPMENTS
TABLE 114 MARSHALL MARINE PRODUCTS: PRODUCTS OFFERED
TABLE 115 MARINOVA: PRODUCTS OFFERED
TABLE 116 AKER BIOMARINE: PRODUCTS OFFERED
TABLE 117 AKER BIOMARINE.: KEY DEVELOPMENTS
TABLE 118 PHARMAMAR: PRODUCTS OFFERED
TABLE 119 PHARMAMAR: KEY DEVELOPMENTS
TABLE 120 CYANOTECH CORPORATION: PRODUCTS OFFERED
TABLE 121 CYANOTECH CORPORATION: KEY DEVELOPMENTS
TABLE 122 ADM: PRODUCTS OFFERED
TABLE 123 GEOMARINE BIOTECHNOLOGIES: PRODUCTS OFFERED
TABLE 124 CP KELCO U.S., INC.: PRODUCT OFFERED
TABLE 125 TERSERA THERAPEUTICS LLC: PRODUCTS OFFERED

LIST OF FIGURES

FIGURE 1 MARKET SYNOPSIS
FIGURE 2 GLOBAL BLUE BIOTECHNOLOGY MARKET
FIGURE 3 BOTTOM-UP AND TOP-DOWN APPROACHES
FIGURE 4 MARKET DYNAMICS: ANALYSIS OF THE BLUE BIOTECHNOLOGY MARKET
FIGURE 5 DRIVER IMPACT ANALYSIS
FIGURE 6 RESTRAINT IMPACT ANALYSIS
FIGURE 7 PORTER'S FIVE FORCES ANALYSIS: INDIA CELL CULTURE MEDIA MARKET
FIGURE 8 GLOBAL BLUE BIOTECHNOLOGY MARKET, PRODUCT SEGMENT ATTRACTIVENESS, 2023-2032 (USD MILLION)
FIGURE 9 GLOBAL BLUE BIOTECHNOLOGY MARKET, BY PRODUCT, 2023 & 2032 (USD MILLION)
FIGURE 10 GLOBAL BLUE BIOTECHNOLOGY MARKET SHARE (%), BY PRODUCT,
FIGURE 11 GLOBAL BLUE BIOTECHNOLOGY MARKET, APPLICATION SEGMENT ATTRACTIVENESS, 2023-2032 (USD MILLION)
FIGURE 12 GLOBAL BLUE BIOTECHNOLOGY MARKET, BY APPLICATION, 2023 & 2032 (USD MILLION)
FIGURE 13 GLOBAL BLUE BIOTECHNOLOGY MARKET SHARE (%), BY APPLICATION,
FIGURE 14 GLOBAL BLUE BIOTECHNOLOGY MARKET, END USER SEGMENT ATTRACTIVENESS, 2023-2032 (USD MILLION)
FIGURE 15 GLOBAL BLUE BIOTECHNOLOGY MARKET, BY END USER, 2023 & 2032 (USD MILLION)
FIGURE 16 GLOBAL BLUE BIOTECHNOLOGY MARKET SHARE (%), BY END USER,
FIGURE 17 NORTH AMERICA MARKET ANALYSIS: BLUE BIOTECHNOLOGY MARKET, 2019-2032 (USD MILLION)
FIGURE 18 NORTH AMERICA: BLUE BIOTECHNOLOGY MARKET, BY COUNTRY, 2023 & 2032 (USD MILLION)
FIGURE 19 NORTH AMERICA: BLUE BIOTECHNOLOGY MARKET SHARE (%), BY COUNTRY,
FIGURE 20 EUROPE MARKET ANALYSIS: BLUE BIOTECHNOLOGY MARKET, 2019-2032 (USD MILLION)
FIGURE 21 EUROPE: BLUE BIOTECHNOLOGY MARKET, BY COUNTRY, 2023 & 2032 (USD MILLION)
FIGURE 22 EUROPE: BLUE BIOTECHNOLOGY MARKET SHARE (%), BY COUNTRY,
FIGURE 23 ASIA-PACIFIC MARKET ANALYSIS: BLUE BIOTECHNOLOGY MARKET, 2019-2032 (USD MILLION)
FIGURE 24 ASIA-PACIFIC: BLUE BIOTECHNOLOGY MARKET, BY COUNTRY, 2023 & 2032 (USD MILLION)
FIGURE 25 ASIA-PACIFIC: BLUE BIOTECHNOLOGY MARKET SHARE (%), BY COUNTRY,
FIGURE 26 REST OF THE WORLD MARKET ANALYSIS: BLUE BIOTECHNOLOGY MARKET, 2019-2032 (USD MILLION)
FIGURE 27 REST OF THE WORLD: BLUE BIOTECHNOLOGY MARKET, BY COUNTRY, 2023 & 2032 (USD MILLION)
FIGURE 28 REST OF THE WORLD: BLUE BIOTECHNOLOGY MARKET SHARE (%), BY COUNTRY,
FIGURE 29 BENCHMARKING OF MAJOR COMPETITORS
FIGURE 30 MAJOR STRATEGY ADOPTED BY KEY PLAYERS IN THE BLUE BIOTECHNOLOGY MARKET
FIGURE 31 BLUE BIOTECHNOLOGY MARKET: COMPETITIVE LANDSCAPE
FIGURE 32 MAJOR PLAYERS SALES (USD MILLION),
FIGURE 33 MAJOR PLAYER R&D EXPENDITURE (USD MILLION),
FIGURE 34 MARINOMED BIOTECH AG: FINANCIAL OVERVIEW SNAPSHOT
FIGURE 35 MARINOVA: SWOT ANALYSIS
FIGURE 36 AKER BIOMARINE: FINANCIAL OVERVIEW SNAPSHOT
FIGURE 37 AKER BIOMARINE: SWOT ANALYSIS
FIGURE 38 PHARMAMAR: FINANCIAL OVERVIEW SNAPSHOT
FIGURE 39 PHARMAMAR: SWOT ANALYSIS
FIGURE 40 CYANOTECH CORPORATION: FINANCIAL OVERVIEW SNAPSHOT
FIGURE 41 ADM: FINANCIAL OVERVIEW SNAPSHOT
FIGURE 42 ADM: SWOT ANALYSIS
FIGURE 43 TERSERA THERAPEUTICS LLC: SWOT ANALYSIS